Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-084893
Filing Date
2022-08-01
Accepted
2022-08-01 21:00:27
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2222258d1_4seq.html 4  
1 OWNERSHIP DOCUMENT tm2222258d1_4seq.xml 4 4987
  Complete submission text file 0001104659-22-084893.txt   6537
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 60 JUBILEE AVENUE, MILTON PARK ABINGDON OXFORDSHIRE X0 X0 OX14 4R
Business Address
Piccina Cintia (Reporting) CIK: 0001907199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 221126557